TrialClinical and vaccine immunology : CVI2015

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.

Dan Apter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.